Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.
Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.
The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.
Cancer Research UK scientists have shown that a protein in urine could be a powerful indicator of prostate cancer risk, according to a study published in PLoS ONE.
A simple urine test could revolutionise the way doctors diagnose bladder cancer according to a new study by Cancer Research UK.